Cargando…

Health-related quality of life in patients with implantable cardioverter defibrillators in Sweden: a cross-sectional observational trial

OBJECTIVES: Decisions regarding implantable cardioverter defibrillators (ICDs) must consider information about presumed health-related quality of life (HRQL). The purpose of the study was to assess HRQL in patients with ICD and compare it to a Swedish age-matched and sex-matched population. DESIGN:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Magnusson, Peter, Mattsson, Gustav, Wallhagen, Marita, Karlsson, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273444/ https://www.ncbi.nlm.nih.gov/pubmed/34244266 http://dx.doi.org/10.1136/bmjopen-2020-047053

Ejemplares similares

Health status measured by Kansas City Cardiomyopathy Questionnaire-12 in primary prevention implantable cardioverter defibrillator patients with heart failure
por: Mattsson, Gustav, et al.
Publicado: (2021)

Quality of Life in Patients with an Implantable Cardioverter Defibrillator: A Systematic Review
por: Tomzik, Juliane, et al.
Publicado: (2015)

Patient-reported feasibility of chest and thumb ECG after cryptogenic stroke in Sweden: an observational study
por: Magnusson, Peter, et al.
Publicado: (2020)

A protocol for a prospective observational study using chest and thumb ECG: transient ECG assessment in stroke evaluation (TEASE) in Sweden
por: Magnusson, Peter, et al.
Publicado: (2018)

Long‐term follow‐up of implantable cardioverter defibrillator patients with regard to appropriate therapy, complications, and mortality
por: Mattsson, Gustav, et al.
Publicado: (2020)

Economic analysis of remote monitoring in patients with implantable cardioverter defibrillators or cardiac resynchronization therapy defibrillators in the Trento area, Italy
por: Marini, Massimiliano, et al.
Publicado: (2023)

Management of hemodynamically stable wide QRS complex tachycardia in patients with implantable cardioverter defibrillators
por: Regoli, François D., et al.
Publicado: (2023)

Lead Abandonment and Subcutaneous Implantable Cardioverter-Defibrillator (S-ICD) Implantation in a Cohort of Patients With ICD Lead Malfunction
por: Russo, Vincenzo, et al.
Publicado: (2021)

Myocardial Scar Characterization and Future Ventricular Arrhythmia in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter-Defibrillator
por: Noordman, Alwin B. P., et al.
Publicado: (2021)

Quality of Life in Patients with Implantable Cardioverter Defibrillators
por: Francis, Johnson, et al.
Publicado: (2006)

Association of Night-Time Heart Rate With Ventricular Tachyarrhythmias, Appropriate and Inappropriate Implantable Cardioverter-Defibrillator Shocks
por: Sun, Xuerong, et al.
Publicado: (2021)

Primary prevention implantable cardioverter defibrillator in cardiac resynchronization therapy recipients with advanced chronic kidney disease
por: Goldenberg, Ido, et al.
Publicado: (2023)

Racial differences in setting of implantable cardioverter-defibrillator placement in older adults with heart failure and association with disparate post-implant outcomes
por: Akhabue, Ehimare, et al.
Publicado: (2023)

Case report: An unusual case of phrenic nerve stimulation in a patient with single chamber implantable cardioverter defibrillator
por: De Innocentiis, Carlo, et al.
Publicado: (2023)

Primary prevention implantable cardioverter defibrillator in patients with non-ischaemic cardiomyopathy: a meta-analysis of randomised controlled trials
por: Barakat, Amr F, et al.
Publicado: (2017)

Sex Differences in Physical Activity and Its Association With Cardiac Death and All-Cause Mortality in Patients With Implantable Cardioverter-Defibrillators
por: Li, Xiaoyao, et al.
Publicado: (2020)

N-Terminal Pro-B-Type Natriuretic Peptide in Risk Stratification of Heart Failure Patients With Implantable Cardioverter-Defibrillator
por: Deng, Yu, et al.
Publicado: (2022)

Implantable cardioverter defibrillator for primary prevention in patients with non-ischemic cardiomyopathy in the era of novel therapeutic agents- meta-analysis
por: Kolben, Yotam, et al.
Publicado: (2023)

Prognostic impact of implantable cardioverter defibrillators and associated adverse events in patients with continuous flow left ventricular assist devices
por: Pausch, Jonas, et al.
Publicado: (2023)

Impairment of Quality of Life in Patients with Implanted Subcutaneous Cardioverter Defibrillator (S-ICD) Compared to Implanted Transvenous Cardioverter Defibrillator Therapy
por: Thienel, Manuela, et al.
Publicado: (2022)

Absence of Obesity Paradox in All-Cause Mortality Among Chinese Patients With an Implantable Cardioverter Defibrillator: A Multicenter Cohort Study
por: Zhou, Bin, et al.
Publicado: (2021)

Diagnostic yield of chest and thumb ECG after cryptogenic stroke, Transient ECG Assessment in Stroke Evaluation (TEASE): an observational trial
por: Magnusson, Peter, et al.
Publicado: (2020)

Non-linear Association Between Body Mass Index and Ventricular Tachycardia/Ventricular Fibrillation in Patients With an Implantable Cardioverter-Defibrillator or Cardiac Resynchronization Therapy Defibrillator: A Multicenter Cohort Study
por: Zhou, Bin, et al.
Publicado: (2020)

Cardiac magnetic resonance outperforms echocardiography to predict subsequent implantable cardioverter defibrillator therapies in ST-segment elevation myocardial infarction patients
por: Marcos-Garcés, Víctor, et al.
Publicado: (2023)

Assessing physical activity with the wearable cardioverter defibrillator in patients with newly diagnosed heart failure
por: Iliodromitis, Konstantinos, et al.
Publicado: (2023)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Evolution of Pacemakers and Implantable Cardioverter Defibrillators (ICDs) in Cardiology
por: Sahu, Palash, et al.
Publicado: (2023)

Case report: Implantable cardioverter-defibrillator implantation with optimal medical treatment for lethal ventricular arrhythmia caused by recurrent coronary artery spasm due to tyrosine kinase inhibitors
por: Jin, Jifu, et al.
Publicado: (2023)

The Screen-ICD trial. Screening for anxiety and cognitive therapy intervention for patients with implanted cardioverter defibrillator (ICD): a randomised controlled trial protocol
por: Berg, Selina Kikkenborg, et al.
Publicado: (2016)

Interaction between electrical storm and left ventricular ejection fraction as predictors of mortality in patients with implantable cardioverter defibrillator: A Chinese cohort study
por: Zhai, Zhengqin, et al.
Publicado: (2022)

The development of a decision aid for shared decision making in the Dutch implantable cardioverter defibrillator patient population: A novel approach to patient education
por: Yilmaz, Dilek, et al.
Publicado: (2022)

Genetic Clues on Implantable Cardioverter-Defibrillator Placement in Young-Age Hypertrophic Cardiomyopathy: A Case Report of Novel MYH7 Mutation and Literature Review
por: Li, Xing, et al.
Publicado: (2021)

Implantable Cardioverter-Defibrillator Lead in an Explanted Human Heart
por: Jeong, Hyung Ki, et al.
Publicado: (2022)

MAGNETO cardiography parameters to predict future Sudden Cardiac Death (MAGNETO-SCD) or ventricular events from implantable cardioverter defibrillators: study protocol, design and rationale
por: Lachlan, Thomas, et al.
Publicado: (2020)

‘You can’t start a car when there’s no petrol left’: a qualitative study of patient, family and clinician perspectives on implantable cardioverter defibrillator deactivation
por: Standing, Holly, et al.
Publicado: (2021)

Health-related quality of life in hypertrophic cardiomyopathy patients with implantable defibrillators
por: Magnusson, Peter, et al.
Publicado: (2016)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
por: Begisbayev, Temirkhan, et al.
Publicado: (2022)

Outcomes of early catheter ablation for ventricular tachycardia in adult patients with structural heart disease and implantable cardioverter-defibrillator: An updated systematic review and meta-analysis of randomized trials
por: Shalganov, Tchavdar, et al.
Publicado: (2022)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6otmb0o5ulcctoi3emljl3u7la